Clinical Trials Directory

Trials / Terminated

TerminatedNCT02050724

ThoHSpEkt Thoracoscopic Ectomy of Radioactively Marked Pulmonary Nodules With Free-hand SPECT

Thorakoskopische Handheld-SPECT Gesteuerte Ektomie Von Radioaktiv-markierten Pulmonalen Rundherden. Proof of Feasibility of Thoracoscopic Ectomy of Radioactively Marked Pulmonary Nodules With the Help of Free-hand SPECT.

Status
Terminated
Phase
Phase 2
Study type
Interventional
Enrollment
11 (actual)
Sponsor
Cantonal Hospital of St. Gallen · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Title ThoHSpEkt Study Design Pilot Study concerning the technical operative methods and a phase II study concerning the radiopharmaceutical (therapeutic-explorative study with an approved drug in a new indication) Location Kantonsspital St.Gallen Aim Proof of feasibility of thoracoscopic ectomy of radioactively marked pulmonary nodules with the help of free-hand SPECT. Background In the Cantonal Hospital of St.Gallen an average of 30 - 40 patients will be operated with thoracoscopic ectomy for a pulmonary nodule. When localisation of the nodule is not possible a switch to minithoracotomy is performed. Study intervention Marking of pulmonary nodules with radioactivity. Free-hand SPECT guided surgery Risks Risks of bronchoscopic or CT-intervention Radiation risk (minimal) Rational for patient number 10 patients for each group are enough to prove the feasibility, to manage difficulties and to record complications Duration approximately 24 months.

Conditions

Interventions

TypeNameDescription
DRUGRadioactive labelling of pulmonary nodulesApplication directly into a pulmonary nodule
DEVICECT guided radioactive labellingCT guided puncture is a standard procedure in radiology. In this study it is used to mark pulmonary nodules for the following thoracoscopic surgery, done with a handheld-SPECT device.
DEVICEElectromagnetic guided bronchoscopic radioactive labellingElectromagnetic guided bronchoscopy is a standard procedure. In this study it is used to mark pulmonary nodules.

Timeline

Start date
2013-11-01
Primary completion
2016-12-31
Completion
2016-12-31
First posted
2014-01-31
Last updated
2017-02-02

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT02050724. Inclusion in this directory is not an endorsement.